EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predominance of In‐Field Recurrence After Radiotherapy for Sinonasal Cancer: A Single‐Center Retrospective Study

M de Ridder, L J van de Velde iD, T de Bie, R van Noortwijk, C P J Raaijmakers, E H Voormolen, W W Braunius, R de Bree iD, G E Breimer, L A Devriese, E J Smid, J A Rijken

Head & Neck · 2026

DOI: 10.1002/hed.70287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2026. Verfasst von M de Ridder und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Paranasal Sinus Neoplasms. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sinonasal malignancies (SNM) are rare, heterogeneous tumors with poor prognosis. There is an unmet need to improve treatment outcomes. Despite advances in imaging and molecular classification, optimal curative radiotherapy (RT) strategies remain undefined. We analyzed the pattern of failure after RT, focusing in depth on local recurrence.

Methods

This retrospective cohort study included 104 SNM patients treated with curative‐intent RT (either primary or after endoscopic surgery) at a tertiary center between 2010 and 2022. Local recurrences were delineated on follow‐up imaging and registered to pretreatment plans. Recurrence location was classified as in‐field, marginal, or out‐of‐field based on dose at the center of mass.

Results

Local recurrence rate was 25%. Most local recurrences (81%) occurred in‐field in the high‐dose region (> 95% of prescribed dose), with a median dose of 65 Gy. Perineural spread accounted for most out‐of‐field failures. Local recurrence significantly impaired disease‐specific survival.

Conclusions

Local failures after RT for SNM predominantly arise in‐field within adequately irradiated volumes, suggesting biological radioresistance. These findings support the need for histology‐driven, biologically tailored treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm Recurrence, LocalParanasal Sinus NeoplasmsHumansRetrospective StudiesFemaleMaleMiddle AgedAgedAged, 80 and overAdultRadiotherapy DosageCohort Studies

Stichwörter der Autor:innen

malignancyradiotherapyrecurrencesinonasal cancer

Autor:innen und Institutionen

  • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Department of Neurosurgery, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.

ORCID-Profile: L J van de Velde, R de Bree

Zitieren

APA

de Ridder, M., van de Velde, L. J., de Bie, T., van Noortwijk, R., Raaijmakers, C. P. J., Voormolen, E. H., Braunius, W. W., de Bree, R., Breimer, G. E., Devriese, L. A., Smid, E. J., & Rijken, J. A. (2026). Predominance of In‐Field Recurrence After Radiotherapy for Sinonasal Cancer: A Single‐Center Retrospective Study. Head & Neck. https://doi.org/10.1002/hed.70287

Vancouver

de Ridder M, van de Velde LJ, de Bie T, van Noortwijk R, Raaijmakers CPJ, Voormolen EH, et al. Predominance of In‐Field Recurrence After Radiotherapy for Sinonasal Cancer: A Single‐Center Retrospective Study. Head & Neck. 2026. doi:10.1002/hed.70287

BibTeX
@article{deRidder2026,
  author = {de Ridder, M and van de Velde, L J and de Bie, T and van Noortwijk, R and Raaijmakers, C P J and Voormolen, E H and Braunius, W W and de Bree, R and Breimer, G E and Devriese, L A and Smid, E J and Rijken, J A},
  title = {Predominance of In‐Field Recurrence After Radiotherapy for Sinonasal Cancer: A Single‐Center Retrospective Study},
  journal = {Head & Neck},
  year = {2026},
  doi = {10.1002/hed.70287}
}
Kostenlos starten →